Back
Innodata Vs. Monopar Therapeutics Industry Stock Comparison
Buy
51
INOD
Innodata
Last Price:
$39.21
Seasonality Move:
7.58%
Sell
31
MNPR
Monopar Therapeutics
Last Price:
$32.88
Seasonality Move:
-27.37%
Sell
31
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $33.52. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $33.52Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.52 | Buy |
Relative Strength Index (14 RSI): | 46.45 | Sell |
Chaikin Money Flow: | -2514869 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.51 - 44.47) | Sell |
Bollinger Bands (100): | (34.17 - 48.33) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.88 | Sell |
Relative Strength Index (14 RSI): | 44.51 | Sell |
Chaikin Money Flow: | -17891 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.82 - 37.44) | Sell |
Bollinger Bands (100): | (32.07 - 43.25) | Sell |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.74 | Sell |
20-day SMA: | 41.14 | Sell |
50-day SMA: | 37.91 | Buy |
200-day SMA: | 34.67 | Buy |
8-day EMA: | 42.87 | Sell |
20-day EMA: | 41.71 | Sell |
50-day EMA: | 40.22 | Sell |
200-day EMA: | 34.6 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.23 | Sell |
20-day SMA: | 34.66 | Sell |
50-day SMA: | 36.88 | Sell |
200-day SMA: | 26.2 | Buy |
8-day EMA: | 34.36 | Sell |
20-day EMA: | 35.08 | Sell |
50-day EMA: | 36.02 | Sell |
200-day EMA: | 28.02 | Buy |
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.06 per share, and an increase next year of $0.40 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.11 per share.
Innodata Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |